Focus on four key therapeutic areas

We are a world leading pharmaceutical group in cardiology and the treatment of venous diseases. In oncology, we are moving up a gear to become a renowned and innovative player. We are also involved in metabolic diseases, neuroscience and immune-inflammatory diseases. To increase the pace of innovation oriented to meet patient needs, we champion collaboration and constant dialogue between those involved in health care in both the public and private sectors, it takes an open and collaborative approach, working with academic partners, pharmaceutical groups and biotech companies.

Putting patients at the heart of our strategy

We put patients and innovation at the heart of everything we do. To meet their needs, we work with patients at every stage of the medicine life cycle—from research to appropriate use—before, during and after treatment.

We believe it is essential. For science. For patients.

Servier’s medicines treat patients in over 150 countries.

Learn more: Servier – About us